Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02460913Phase 2Completed
Phase 2, randomised, open-label trial (2 arms), sponsored by Université de Monastir. Primary endpoint: Change of pain severity from baseline. Started Apr 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02460913.